Novo Nordisk launches Wegovy's first and only multi-month subscription plan approved by the U.S. Food and Drug Administration (FDA), offering savings of up to $1,200 per year.
2026-03-31
Novo Nordisk launches Wegovy's first and only multi-month subscription plan approved by the U.S. Food and Drug Administration (FDA), offering savings of up to $1,200 per year.
